Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural products targeting tumour angiogenesis
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth
British Journal of Pharmacology (2023)
Open Access | Times Cited: 20

Showing 20 citing articles:

Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy
Andrej Jenča, David K. Mills, Hadis Ghasemi, et al.
Biologics (2024) Vol. Volume 18, pp. 229-255
Open Access | Times Cited: 10
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis
Mengrui Yang, Yufeng Mu, Xiaoyun Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116783-116783
Open Access | Times Cited: 8
Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
Jiaming Lei, Jianbao Yang, Cuiyu Bao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Natural products: Call for hard evidence
Francesco Visioli
British Journal of Pharmacology (2024) Vol. 181, Iss. 16, pp. 3010-3011
Open Access | Times Cited: 2
Perspectives on organ-on-a-chip technology for natural products evaluation
Xin Wang, Yu‐Hang Miao, Xiaomin Zhao, et al.
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420013-9420013
Open Access | Times Cited: 2
Nature-Inspired Compounds: Synthesis and Antibacterial Susceptibility Testing of Eugenol Derivatives against H. pylori Strains
Simone Carradori, Alessandra Ammazzalorso, Sofia Niccolai, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1317-1317
Open Access | Times Cited: 6
Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
Tiago Azevedo, Tiago Ferreira, Sheila I. Peña‐Corona, et al.
Food Frontiers (2024)
Open Access | Times Cited: 1
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies
Manzar Alam, Mehak Gulzar, Salman Akhtar, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability
Tengfei Chen, Jun Chen, Qiuyun Chen, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1424-1437
Open Access
From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches
Adel Alblihy
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Natural products: call for hard evidence
Francesco Visioli
Authorea (Authorea) (2024)
Open Access
In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer
Mohamed Elbadawi, Thomas Efferth
Handbook of experimental pharmacology (2024)
Closed Access
Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids
Xian Lin, Tengyu Lin, Meng Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116871-116871
Open Access
8’,9’-Bis-nor-neolignans from Cedrela odorata and their antiangiogenic activity
Valeria Iobbi, Shiva Pouramin Arabi, Angela Bisio, et al.
Phytochemistry Letters (2024) Vol. 64, pp. 13-18
Closed Access
Promising Phytoconstituents in Antiangiogenesis Drug Development
Ibrahim M. Abu‐Reidah, Amani Taamalli
Nutraceuticals (2024) Vol. 4, Iss. 4, pp. 450-468
Open Access
Harmine and its derivatives: an In-depth review of antitumor mechanisms and structure-activity relationship
Taoufik Akabli, Hamid Toufik, Fatima Lamchouri
Medicinal Chemistry Research (2024)
Closed Access
The role of N6-methyladenosine modification in tumor angiogenesis
Qin Li, Xinya Zeng, Xinze Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Elucidating the molecular mechanism of angiogenic activity of sulfate glycosaminoglycan derived from fish swim bladder in human umbilical vein endothelial cells
Kun Yang, Runqi Guo, Jing Chen, et al.
Journal of Functional Foods (2024) Vol. 123, pp. 106611-106611
Open Access
Injectable polydopamine/curcumin dual-modified polylactic acid/polycaprolactone coaxial staple fibers for chronotropic treatment of oral squamous cell carcinoma
Xin Chen, Lei Sun, Yujie Ning, et al.
International Journal of Biological Macromolecules (2024), pp. 139094-139094
Closed Access
Page 1

Scroll to top